Outsourcing & Partnering drug discovery

Differding Consulting offers its customers an improved productivity and innovation in pharmaceutical preclinical research by Outsourcing and Partnering Drug Discovery activities, projects and programmes through:

  • Assistance in optimizing outsourcing practices and refining strategies
  • Identification of opportunities for strategic collaborations and synergies
  • Identification, audit and selection of relevant and reliable partners and contract research organizations
  • Assistance in contract negotiation and initiation of collaboration
  • Assistance in project, performance and alliance management


The value of our services is based on a reduction of risk inherent to outsourcing via:

  • A unique first-hand knowledge of the drug discovery outsourcing and partnering market, in particular in India
  • An established network of personal contacts with major contract research organizations, and a comprehensive database on Indian drug discovery activities
  • A proven experience in identifying and concluding strategic collaborations
  • A unique personal understanding of India and its culture

 

LATEST NEWS

02.06.2017 | THE DRUG DISCOVERY AND DEVELOPMENT INDUSTRY IN INDIA - TWO DECADES OF PROPRIETARY SMALL-MOLECULE R&D

A comprehensive survey of proprietary drug discovery and development efforts by Indian companies between 1994 and mid-2016, focusing on preclinical and clinical development compounds by company, therapeutic indication, mode of action, target class, and development status. The analysis includes the evolution of the overall pipeline over two decades, attrition rates, in-house developments and contributions to Western pharmaceutical pipelines through licensing agreements.

AVAILABLE OPEN ACCESS

28.01.2018 | THE STORY OF INDIAN PHARMA AND BIOTECH - BOOKS TO READ

For all those who are interested in the recent history of the pharmaceutical and biotechnology industry in India, and who want to go beyond annual reports and corporate presentations, four recently published biographies are must-reads. Whereas three books are autobiographies, a fourth one is the result of countless interviews of key players (scientists, current and past coworkers, pharma rivals, ministries, etc…), and gives unique insights into the development of biotechnology in India.

READ MORE